Antiretroviral therapy for tuberculosis control in nine African countries (Q34320245)

1 August 2017

title

Antiretroviral therapy for tuberculosis control in nine African countries (English)

1 reference

1 August 2017

main subject

anti-retroviral agent

0 references

0 references

Philippe Glaziou

4

0 references

Brian Williams

object named as

Brian G Williams

series ordinal

1

0 references

Christopher Dye

series ordinal

6

object named as

Christopher Dye

1 reference

1 August 2017

3

Kevin M De Cock

1 reference

1 August 2017

Reuben Granich

2

1 reference

1 August 2017

Abhishek Sharma

series ordinal

5

1 reference

1 August 2017

language of work or name

English

0 references

publication date

25 October 2010

1 reference

Proceedings of the National Academy of Sciences of the United States of America

1 August 2017

published in

1 reference

1 August 2017

volume

107

1 reference

1 August 2017

issue

45

1 reference

1 August 2017

page(s)

19485-19489

1 reference

Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984151

Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984151

Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984151

Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984151

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984151

Effect of early versus deferred antiretroviral therapy for HIV on survival

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984151

Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984151

Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984151

Incidence and risk factors for tuberculosis in HIV-positive subjects by HAART status

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984151

Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984151

Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984151

The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984151

Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984151

HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984151

Low CD4+ T-lymphocyte values in human immunodeficiency virus-negative adults in Botswana

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984151

Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984151

Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984151

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984151

Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy. EuroSIDA Study Group JD.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984151

HIV infection, antiretroviral therapy, and CD4+ cell count distributions in African populations

6 July 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1005660107

CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1005660107

Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1005660107

Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1005660107

Mortality among HIV-positive postpartum women with high CD4 cell counts in Zimbabwe

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1005660107

Tuberculosis Fueled by HIV: Putting Out the Flames

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1005660107

Factors Associated with the Development of Opportunistic Infections in HIV‐1–Infected Adults with High CD4+Cell Counts: A EuroSIDA Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1005660107

A serostatus-based approach to HIV/AIDS prevention and care in Africa

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20974976

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Universal voluntary testing and treatment for prevention of HIV transmission

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20974976

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

HIV-associated tuberculosis in the era of highly active antiretroviral therapy. The Adult/Adolescent Spectrum of HIV Disease Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20974976

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1073/PNAS.1005660107

1 reference

1 August 2017

0 references

1 reference

1 August 2017

1 reference